Skip to main content

Amphetamine / Dextroamphetamine News

ADHD Meds Tied to Heart Damage in Young Adult Users

WEDNESDAY, March 27, 2024 – ADHD stimulant medications like Ritalin or Adderall appear linked to a heightened risk for cardiomyopathy (a weakening of the heart muscle), and the risk grows with time,...

In Utero Rx Stimulant Exposure Not Tied to Later Neurodevelopmental Issues

THURSDAY, Feb. 1, 2024 --Amphetamine/dextroamphetamine and methylphenidate exposure in utero does not appear to increase the risk for childhood neurodevelopmental disorders, according to a study...

ADHD: What Parents Need to Know

MONDAY, Sept. 4, 2023 – Lots of children and adolescents have the condition known as ADHD, or attention-deficit/hyperactivity disorder. What should parents know? A number of treatments exist to help...

After U.S. Warns of Counterfeit Pills Laced With Fentanyl, Mexico Shuts Down 23 Pharmacies

WEDNESDAY, Aug. 9, 2023 – Following a four-day raid, Mexico has closed 23 pharmacies in Caribbean resorts of Cancun, Playa del Carmen and Tulum for irregular pill sales. Last spring, the United...

Taking ADHD Meds Won't Raise a Kid's Odds for Drug Abuse Later: Study

THURSDAY, July 6, 2023 – Stimulant medications like Ritalin are commonly prescribed to help treat the symptoms of attention deficit hyperactivity disorder, but there have been concerns the drugs may...

FDA Medwatch Alert: FDA Updating Warnings to Improve Safe Use of Prescription Stimulants Used to Treat ADHD and Other Conditions

What safety concern is FDA announcing? To address continuing concerns of misuse, abuse, addiction, and overdose of prescription stimulants, the U.S. Food and Drug Administration (FDA) is requiring...

FDA Approves Mydayis (mixed salts of a single-entity amphetamine product) – A New Once-Daily Option for ADHD

Lexington, Mass., USA – June 20, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) has approved Mydayis (mixed salts of a single-entity amp...

FDA Medwatch Alert: Teva's Adderall 30 mg Tablets: Counterfeit Product - Contains Wrong Active Ingredients

ISSUE: FDA is warning consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries' Adderall 30 milligram tablets that is being purchased on the Internet....

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Attention-Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Fatigue

Related drug support groups

Adderall, Adderall XR

Amphetamine / Dextroamphetamine patient information at Drugs.com